Ironwood Pharmaceuticals, Inc. (IRWD) Earnings History
Turnaround19 years of earnings data (2007–2025) · Recovering earnings after a multi-year decline
Loading earnings history...
Ironwood Pharmaceuticals, Inc. (IRWD) Earnings Overview
As of June 22, 2026, Ironwood Pharmaceuticals, Inc. (IRWD) reported trailing twelve-month net income of $102M. The company earned $0.61 per diluted share over the past four quarters, with a net profit margin of 8.1%.
Looking at the long-term picture, IRWD's 5-year EPS compound annual growth rate (CAGR) stands at -25.6%, signaling declining earnings. The company achieved its highest annual net income of $528M in fiscal 2021.
Ironwood Pharmaceuticals, Inc. maintains positive profitability with a gross margin of 100.0%, operating margin of 40.1%, and net margin of 8.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PTGX (-$115M net income, -282.8% margin), ARDX (-$58M net income, -15.1% margin), CPIX (-$7M net income, -6.4% margin), IRWD has outperformed on profitability metrics. Compare IRWD vs PTGX →
IRWD Earnings vs Peers
Earnings metrics vs comparable public companies
IRWD Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $24M | +2629.2% | $119M | $0.15 | 8.1% | 40.1% |
| 2024 | $880,000 | +100.1% | $93M | $0.01 | 0.3% | 26.5% |
| 2023 | -$1.00B | -672.5% | -$945M | $-6.45 | -226.4% | -213.5% |
| 2022 | $175M | -66.9% | $250M | $0.96 | 42.6% | 61.0% |
| 2021 | $528M | +397.7% | $232M | $3.21 | 127.7% | 56.1% |
| 2020 | $106M | +393.7% | $143M | $0.66 | 27.3% | 36.7% |
| 2019 | $22M | +107.6% | $120M | $-0.10 | 5.0% | 28.0% |
| 2018 | -$282M | -141.5% | -$239M | $-1.85 | -81.5% | -68.9% |
| 2017 | -$117M | -43.1% | -$77M | $-0.78 | -39.2% | -25.9% |
| 2016 | -$82M | +42.7% | -$52M | $-0.56 | -29.8% | -18.9% |
| 2015 | -$143M | +24.8% | -$102M | $-1.00 | -95.4% | -68.3% |
| 2014 | -$190M | +30.5% | -$169M | $-1.39 | -248.1% | -221.6% |
| 2013 | -$273M | -275.6% | -$252M | $-2.35 | -1192.3% | -1101.4% |
| 2012 | -$73M | -12.0% | -$73M | $-0.68 | -48.3% | -48.4% |
| 2011 | -$65M | -22.4% | -$66M | $-0.65 | -98.5% | -100.4% |
| 2010 | -$53M | +25.6% | -$61M | $-0.59 | -120.8% | -138.6% |
| 2009 | -$71M | -32.1% | -$73M | $-1.02 | -197.2% | -201.6% |
| 2008 | -$54M | -2.1% | -$56M | $-0.77 | -242.5% | -251.7% |
| 2007 | -$53M | - | -$58M | $-0.70 | -504.1% | -550.6% |
Download Data
Export IRWD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
19+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IRWD — Frequently Asked Questions
Quick answers to the most common questions about buying IRWD stock.
What is IRWD earnings per share (EPS)?
IRWD trailing twelve-month (TTM) diluted EPS is $0.61, reflecting N/A year-over-year growth. The 5-year EPS CAGR is -25.6%. Complete EPS history from 2007 to 2025 is available in the table on this page.
What is Ironwood Pharmaceuticals, Inc.'s net income?
Ironwood Pharmaceuticals, Inc. (IRWD) trailing twelve-month net income is $102M as of 2025. Earnings declined N/A year-over-year. Ironwood Pharmaceuticals, Inc. has been profitable for 2 consecutive years.
Is IRWD profitable?
Yes, IRWD is profitable with a TTM net income of $102M and a net profit margin of +8.1%. Ironwood Pharmaceuticals, Inc. has generated profits for 2 consecutive years.
What is IRWD's earnings growth rate?
IRWD compound annual EPS growth rates (CAGR): 1-Year: +2627.3%, 3-Year: -46.1%, 5-Year: -25.6%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2007 to 2025.
What are IRWD's profit margins?
Ironwood Pharmaceuticals, Inc. net profit margin is +8.1%, operating margin is +40.1%, and gross margin is +100.0%. Margins are within a typical range for the sector. Return on Equity is N/A.
Is IRWD growing earnings?
IRWD TTM EPS: $0.61. Net income: $102M. YoY earnings change: N/A.
What was IRWD's best earnings year?
Ironwood Pharmaceuticals, Inc.'s highest annual net income on record is $528M, achieved in fiscal year 2021. Earnings history on this page spans 2007 to 2025 and includes all annual and quarterly figures.
What were IRWD's earnings last quarter?
IRWD's most recent reported quarter was Q1 2026. Net income was $41M with diluted EPS of $0.24. For a full breakdown of all quarters, see the quarterly earnings table on this page.